·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ÀÓÁ¾ÈÆ Çѹ̻çÀ̾𽺠´ëÇ¥, ÁÖ½Ä 105¸¸ÁÖ ¸Åµµ ±â»çÀÔ·Â : 24.11.15 16:36:47 0 °¡ ÇÃÄ£Ãß°¡ AD 11¿ù 4ÁÖÂ÷ ¸ÅÃ⠺м®ÀÌ ÇÊ¿äÇϸé? BRPInsight [µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] Çѹ̻çÀ̾𽺴 ÀÓÁ¾ÈÆ ´ëÇ¥°¡ º¸À¯ ÁÖ½Ä 105¸¸ÁÖ¸¦ ½Ã°£¿Ü¸Å¸Å·Î óºÐÇß´Ù°í 15ÀÏ °ø½ÃÇß´Ù. ÀÓ ´ëÇ¥´Â º¸À¯ ÁÖ½Ä 642¸¸808ÁÖ Áß 16.4%¸¦ óºÐÇß´Ù. Áö³ 14ÀÏ Á¾°¡ 3¸¸2500¿øÀ» Àû¿ëÇϸé ÁÖ½Ä Ã³ºÐ ±Ý¾×Àº 341¾ï¿ø ±Ô¸ð·Î Ãß»êµÈ´Ù. ÀÓ ´ëÇ¥ÀÇ Çѹ̻çÀ̾𽺠ÁöºÐÀ²Àº 9.39%¿¡¼ 7.85%·Î ³·¾ÆÁø´Ù. X AD »çÀüµî·Ï GO À̺¥Æ®Âü¿© ¡æ õ½ÂÇö ±âÀÚ(1000@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [°æ±âµµ ±¤ÁÖ] º¹»ê³ªÀ̽º °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â [¸ÓÅ©ÄÚ¸®¾Æ] Regulatory Affairs Specialist ¹Ù·Î°¡±â Á¦¾à ¿µ¾÷ ½ÅÀÔ ¹× °æ·Â ä¿ë(¾Èµ¿) ¹Ù·Î°¡±â Çâ³²&¾È¼º Á¦Á¶°ü¸® ¾à»ç ä¿ë(½ÅÀÔ¿ì´ë) ¹Ù·Î°¡±â ¹é¾Ï°øÀå QA¾à»ç ä¿ë °æ·Â¹«°ü ¹Ù·Î°¡±â °³¹ßº»ºÎ ±âȹ, RA ÆÀÀå±Þ ä¿ë(°æ·Â 10³â¡è) ¹Ù·Î°¡±â ¸ÂÃ㿵¾çÁ¦ ¸ÞµðÄÚÄ¡¿¡¼ ÇÁ¸®·£¼(¿Â¶óÀÎ »ó´ã À§ÁÖ) ¾à»ç¸¦ ¸ðÁýÇÕ´Ï´Ù.(¼ö±Ý ¾ß°£/ÁÖ¸» »ó´ã) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀÓÁ¾ÈÆ Çѹ̻çÀ̾𽺠´ëÇ¥, ÁÖ½Ä 105¸¸ÁÖ ¸Åµµ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÀÓÁ¾ÈÆ Çѹ̻çÀ̾𽺠´ëÇ¥, ÁÖ½Ä 105¸¸ÁÖ ¸Åµµ ±â»çÀÔ·Â : 24.11.15 16:36:47 0 °¡ ÇÃÄ£Ãß°¡ AD 11¿ù 4ÁÖÂ÷ ¸ÅÃ⠺м®ÀÌ ÇÊ¿äÇϸé? BRPInsight [µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] Çѹ̻çÀ̾𽺴 ÀÓÁ¾ÈÆ ´ëÇ¥°¡ º¸À¯ ÁÖ½Ä 105¸¸ÁÖ¸¦ ½Ã°£¿Ü¸Å¸Å·Î óºÐÇß´Ù°í 15ÀÏ °ø½ÃÇß´Ù. ÀÓ ´ëÇ¥´Â º¸À¯ ÁÖ½Ä 642¸¸808ÁÖ Áß 16.4%¸¦ óºÐÇß´Ù. Áö³ 14ÀÏ Á¾°¡ 3¸¸2500¿øÀ» Àû¿ëÇϸé ÁÖ½Ä Ã³ºÐ ±Ý¾×Àº 341¾ï¿ø ±Ô¸ð·Î Ãß»êµÈ´Ù. ÀÓ ´ëÇ¥ÀÇ Çѹ̻çÀ̾𽺠ÁöºÐÀ²Àº 9.39%¿¡¼ 7.85%·Î ³·¾ÆÁø´Ù. X AD »çÀüµî·Ï GO À̺¥Æ®Âü¿© ¡æ õ½ÂÇö ±âÀÚ(1000@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [°æ±âµµ ±¤ÁÖ] º¹»ê³ªÀ̽º °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â [¸ÓÅ©ÄÚ¸®¾Æ] Regulatory Affairs Specialist ¹Ù·Î°¡±â Á¦¾à ¿µ¾÷ ½ÅÀÔ ¹× °æ·Â ä¿ë(¾Èµ¿) ¹Ù·Î°¡±â Çâ³²&¾È¼º Á¦Á¶°ü¸® ¾à»ç ä¿ë(½ÅÀÔ¿ì´ë) ¹Ù·Î°¡±â ¹é¾Ï°øÀå QA¾à»ç ä¿ë °æ·Â¹«°ü ¹Ù·Î°¡±â °³¹ßº»ºÎ ±âȹ, RA ÆÀÀå±Þ ä¿ë(°æ·Â 10³â¡è) ¹Ù·Î°¡±â ¸ÂÃ㿵¾çÁ¦ ¸ÞµðÄÚÄ¡¿¡¼ ÇÁ¸®·£¼(¿Â¶óÀÎ »ó´ã À§ÁÖ) ¾à»ç¸¦ ¸ðÁýÇÕ´Ï´Ù.(¼ö±Ý ¾ß°£/ÁÖ¸» »ó´ã) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀÓÁ¾ÈÆ Çѹ̻çÀ̾𽺠´ëÇ¥, ÁÖ½Ä 105¸¸ÁÖ ¸Åµµ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÀÓÁ¾ÈÆ Çѹ̻çÀ̾𽺠´ëÇ¥, ÁÖ½Ä 105¸¸ÁÖ ¸Åµµ ±â»çÀÔ·Â : 24.11.15 16:36:47 0 °¡ ÇÃÄ£Ãß°¡ AD 11¿ù 4ÁÖÂ÷ ¸ÅÃ⠺м®ÀÌ ÇÊ¿äÇϸé? BRPInsight [µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] Çѹ̻çÀ̾𽺴 ÀÓÁ¾ÈÆ ´ëÇ¥°¡ º¸À¯ ÁÖ½Ä 105¸¸ÁÖ¸¦ ½Ã°£¿Ü¸Å¸Å·Î óºÐÇß´Ù°í 15ÀÏ °ø½ÃÇß´Ù. ÀÓ ´ëÇ¥´Â º¸À¯ ÁÖ½Ä 642¸¸808ÁÖ Áß 16.4%¸¦ óºÐÇß´Ù. Áö³ 14ÀÏ Á¾°¡ 3¸¸2500¿øÀ» Àû¿ëÇϸé ÁÖ½Ä Ã³ºÐ ±Ý¾×Àº 341¾ï¿ø ±Ô¸ð·Î Ãß»êµÈ´Ù. ÀÓ ´ëÇ¥ÀÇ Çѹ̻çÀ̾𽺠ÁöºÐÀ²Àº 9.39%¿¡¼ 7.85%·Î ³·¾ÆÁø´Ù. X AD »çÀüµî·Ï GO À̺¥Æ®Âü¿© ¡æ õ½ÂÇö ±âÀÚ(1000@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀÓÁ¾ÈÆ Çѹ̻çÀ̾𽺠´ëÇ¥, ÁÖ½Ä 105¸¸ÁÖ ¸Åµµ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö